Furthermore, the escalation of PD-L1 expression in NSCLC has been correlated with the activation of the RAS signaling pathway, a process in which the ROS1 receptor tyrosine kinase plays a pivotal role (34). This evidence concerns the gene ROS1 and non-small cell lung carcinoma.